Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Calquence
Calquence
FDA grants priority review for AstraZeneca’s Calquence sNDA
Pharmaceutical Business Review
Fri, 10/4/24 - 09:26 am
AstraZeneca
Calquence
FDA
priority review
AstraZeneca reports positive data from Phase III mantle cell lymphoma trial
Clinical Trials Arena
Mon, 06/17/24 - 11:21 am
AstraZeneca
clinical trials
Calquence
MCL
mantle cell lymphoma
As Imbruvica bows out, AstraZeneca clinches early Calquence win in newly diagnosed MCL
Fierce Pharma
Thu, 05/2/24 - 11:31 am
AbbVie
JNJ
Imbruvica
AstraZeneca
Calquence
mantle cell lymphoma
AstraZeneca Redefining Cancer Care in Breast Cancer, Leukemia at ASCO
BioSpace
Mon, 06/7/21 - 08:41 pm
AstraZeneca
ASCO 2021
breast cancer
CLL
Lynparza
Calquence
AZ says Calquence is a safer drug than Imbruvica
Pharmaforum
Mon, 01/25/21 - 11:02 am
AstraZeneca
Calquence
Imbruvica
JNJ
AbbVie
CLL
ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice
Fierce Pharma
Sun, 12/6/20 - 07:15 pm
AstraZeneca
BeiGene
JNJ
AbbVie
Calquence
Brukinsa
Imbruvica
CLL
ASH2020
AstraZeneca cancer drug found ineffective for COVID-19
BioPharma Dive
Thu, 11/12/20 - 11:09 pm
AstraZeneca
Calquence
clinical trials
COVID-19
AstraZeneca’s Calquence Showed Improvement In Small Group Of Hospitalized Covid-19 Patients
Forbes
Sat, 06/6/20 - 03:35 pm
AstraZeneca
Calquence
COVID-19
AZ, Lilly join efforts to develop drugs for COVID-19
Pharmaforum
Tue, 04/14/20 - 09:50 am
AstraZeneca
Eli Lilly
COVID-19
olumiant
Calquence
EXCLUSIVE: AstraZeneca’s Calquence Shows Early Promise For COVID-19 Patients
Forbes
Mon, 04/13/20 - 09:35 pm
AstraZeneca
clinical trials
Calquence
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
Pharmaforum
Sun, 12/8/19 - 10:17 pm
AstraZeneca
cancer
Calquence
ASH2019
Imbruvica
JNJ
AbbVie
CLL
AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
BioSpace
Mon, 11/25/19 - 09:46 am
AstraZeneca
FDA
CLL
SLL
Calquence
AstraZeneca's Calquence steps up to challenge Imbruvica with big CLL green light
Fierce Pharma
Thu, 11/21/19 - 06:26 pm
AstraZeneca
Calquence
Imbruvica
CLL
JNJ
AbbVie
Is AbbVie's Imbruvica concerned about AZ's rising Calquence? We've got this covered, execs say
Fierce Pharma
Fri, 11/1/19 - 06:55 pm
AbbVie
Rinvoq
AstraZeneca
Calquence
Imbruvica
AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment
Pharmaforum
Wed, 08/14/19 - 11:01 am
AstraZeneca
Merck
Lynparza
clinical trials
advanced ovarian cancer
ovarian cancer
Calquence
AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition
BioSpace
Thu, 06/27/19 - 06:38 pm
AstraZeneca
clinical trials
Imfinzi
extensive-stage small cell lung cancer
Calquence
CLL
AstraZeneca's Calquence sets Imbruvica in its sights with big CLL survival numbers
Fierce Pharma
Mon, 06/17/19 - 11:21 pm
AstraZeneca
Calquence
CLL
Imbruvica
AstraZeneca ends another Calquence trial early
Pharmaforum
Thu, 06/6/19 - 09:55 am
AstraZeneca
CLL
Calquence
clinical trials
Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises
Endpoints
Tue, 05/7/19 - 10:15 am
AstraZeneca
Calquence
clinical trials
chronic lymphocytic leukemia
AbbVie
JNJ
Imbruvica
AstraZeneca wins US approval for lymphoma drug
Yahoo/AP
Tue, 10/31/17 - 09:24 pm
AstraZeneca
FDA
Calquence
mantle cell lymphoma